Zometa (zoledronic acid) Injection : Cancer and Your Bones Zometa (zoledronic acid) Injection : Cancer and Your BonesZometa (zoledronic acid) Injection : Novartis Oncology
Zometa (zoledronic acid) Injection : Cancer and Your Bones
Zometa (zoledronic acid) : Talk to Your Doctor About Bone Health
Zometa (zoledronic acid) : Being on Zometa Therapy
Zometa (zoledronic acid) : Zometa Patient Resources
Zometa (zoledronic acid) Injection : Glossary
Zometa (zoledronic acid) Injection : Prescribing Information
Zometa (zoledronic acid) : Important Safety Information
Zometa (zoledronic acid) : For Health Care Professionals
Sign up today to receive ongoing bone health information
   

ZOMETA Patient Resources

Link to the Information You Need
Simply click on a link below to find the type of information you are interested in.

Frequently Asked Questions About ZOMETA and Bone Metastases
Get the answers to questions frequently asked about ZOMETA.

 Zometa (zoledronic acid) Injection : Related Links
Questions to Ask Your Doctor About ZOMETA
Frequently Asked Questions About ZOMETA
Frequently Asked Questions About Bone Metastases
Sign up for the Zometa Bone Health Program
  

Get the answers to questions frequently asked about bone metastases.

ZOMETA Reimbursement Information
Learn about assistance and services provided through the Novartis Patient Assistance Program (PAP).

Resources
Link to a variety of organizations that provide information and support to people affected by cancer:

General Cancer Resources
Breast Cancer Resources
Lung Cancer Resources
Prostate Cancer Resources
Multiple Myeloma Resources

ZOMETA Reimbursement Assistance

Getting Assistance for Insurance Issues

Novartis Pharmaceuticals Corporation, makers of ZOMETA, is committed to supporting cancer patients and healthcare professionals that provide oncology care.

Novartis is committed to providing access to our medications for those most in need through the Novartis Pharmaceuticals Corporation's Patient Assistant Program (PAP). The Novartis PAP provides assistance to patients who are U.S. residents experiencing financial hardship and who have no third-party insurance coverage for their medications. The PAP sponsors over 35 of Novartis' life-sustaining/single-sourced medications. For more information, please call 1-800-282-7630 or visit www.pap.novartis.com.

Cancer Resources

The resources below offer information and support for people affected by cancer.

Novartis Oncology, a Novartis Oncology program
www.us.novartisoncology.com

The following organizations and websites are independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for any information they may provide.

General Cancer Resources:

American Cancer Society
www.cancer.org

Cancer Care, Inc.
www.cancercare.org

Cancer Information Service (CIS) of the National Cancer Institute
www.cancer.gov

National Coalition for Cancer Survivorship (NCCS)
www.canceradvocacy.org

Breast Cancer Resources:

African American Breast Cancer Alliance, Inc.(AABCA)
www.geocities.com/aabcainc

Avon's Breast Cancer Awareness Crusade
www.avoncompany.com/women/avoncrusade

BreastCancer.Org
www.breastcancer.org

Breast Cancer Network of Strength
www.networkofstrength.org

Breast Cancer Research Foundation
www.bcrfcure.org

National Breast Cancer Coalition (NBCC)
www.natlbcc.org

The Susan G. Komen Breast Cancer Foundation
www.komen.org

Lung Cancer Resources:

Lung Cancer Alliance
www.alcase.org

Prostate Cancer Resources:

National Prostate Cancer Coalition
www.4npcc.org

Prostate Cancer Foundation
www.prostatecancerfoundation.org

Prostate Cancer Research Institute
www.prostate-cancer.org

Multiple Myeloma Resources:

International Myeloma Foundation
www.myeloma.org

Multiple Myeloma Research Foundation
www.multiplemyeloma.org

Leukemia and Lymphoma Society
www.leukemia.org

 

 
Novartis presents ZOMETA (zoledronic acid) for bone metastasis ZOMETA (zoledronic acid) for bone metastases